A new policy to implement CONSORT guidelines for surgical randomized controlled trials

Annals of Surgery

Volumn 260, Issue 6, 2014, Pages 947-948

  Clavien, Pierre Alain ^a   Lillemoe, Keith D ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKLIST; DECISION MAKING; EDITORIAL; HEALTH CARE POLICY; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGEON; SYSTEMATIC REVIEW (TOPIC); HEALTH CARE PLANNING; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS; SURGERY;

GUIDELINE ADHERENCE; HEALTH PLAN IMPLEMENTATION; HUMANS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURGICAL PROCEDURES, OPERATIVE;

EID: 84922279469     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001057     Document Type: Editorial

References (10)

1. Prescott RJ, Counsell CE, Gillespie WJ, et al. Factors that limit the quality, number and progress of randomised controlled trials. Health Technol Assess. 2007;11: 1-149, iii-iv.
2. Jacquier I, Boutron I, Moher D, et al. The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: A systematic review. Ann Surg. 2006;244: 677-683.
3. Nagendran M, Harding D, Teo W, et al. Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): A cross-sectional study. BMJ Open. 2013;3: E003898.
4. Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273: 408-412.
5. Rennie D. CONSORT revised-improving the reporting of randomized trials. JAMA. 2001;285: 2006-2007.
6. Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340: C332.
7. Boutron I, Moher D, Altman DG, et al. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: Explanation and elaboration. Ann Intern Med. 2008;148: 295-309.
8. Turner L, Shamseer L, Altman DG, et al.Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev. 2012;29: 60.
9. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-Analyses: The PRISMA statement. PLoS Med. 2009;6(7): E1000097.
10. Moher D, Cook DJ, Eastwood S, et al. Improving the quality of reporting of meta-Analysis of randomized controlled trials: The QUOROM statement. Lancet. 1999;354: 1896-1900.